相似文献
1
Mechanism and therapeutic reversal of immune suppression in cancer.癌症免疫抑制的机制与治疗性逆转
Cancer Res. 2007 Jun 1;67(11):5067-9. doi: 10.1158/0008-5472.CAN-07-0897.
2
[Cancer immunotherapy. Importance of overcoming immune suppression].[癌症免疫疗法。克服免疫抑制的重要性]
Medicina (B Aires). 2010;70(6):565-70.
3
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.变应原肿瘤学：过敏和癌症中免疫耐受的相反结局。
Allergy. 2018 Feb;73(2):328-340. doi: 10.1111/all.13311. Epub 2017 Oct 5.
4
Cancer immunology, inflammation, and tolerance: an introduction.癌症免疫学、炎症与耐受性：引言
Virchows Arch. 2019 Apr;474(4):405-406. doi: 10.1007/s00428-019-02547-3.
5
Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.癌症免疫疗法与打破免疫耐受：应对旧挑战的新方法
Cancer Res. 2015 Jan 1;75(1):5-10. doi: 10.1158/0008-5472.CAN-14-2538. Epub 2014 Dec 18.
6
Editorial overview: Cancer Immunotherapy: Are we there yet?编辑概述：癌症免疫疗法：我们到那儿了吗？
Curr Opin Immunol. 2021 Apr;69:iii-v. doi: 10.1016/j.coi.2021.04.008.
7
Immunotherapy in anticancer responses.抗癌反应中的免疫疗法。
Curr Opin Mol Ther. 2004 Feb;6(1):8-9.
8
Integrative strategy for improving cancer immunotherapy.改善癌症免疫疗法的综合策略。
J Mol Med (Berl). 2016 May;94(5):485-7. doi: 10.1007/s00109-016-1424-1.
9
Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.区域引流淋巴结在肿瘤免疫发展中的意义：对癌症免疫治疗的启示。
Cancer Treat Res. 2007;135:223-37. doi: 10.1007/978-0-387-69219-7_17.
10
Directing dendritic cell immunotherapy towards successful cancer treatment.将树突状细胞免疫疗法导向成功的癌症治疗。
Immunotherapy. 2010 Jan;2(1):37-56. doi: 10.2217/imt.09.43.
引用本文的文献
1
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.信迪利单抗用于一线细胞因子诱导的杀伤细胞联合化疗治疗广泛期小细胞肺癌后的维持治疗。
Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022.
2
The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer.三阴性乳腺癌的肿瘤微环境特征
Cancer Manag Res. 2022 Jan 3;14:1-17. doi: 10.2147/CMAR.S316700. eCollection 2022.
3
Retrospective analysis of the efficacy of cytokine-induced killer cell immunotherapy combined with first-line chemotherapy in patients with metastatic colorectal cancer.细胞因子诱导的杀伤细胞免疫疗法联合一线化疗治疗转移性结直肠癌患者疗效的回顾性分析
Clin Transl Immunology. 2020 Feb 19;9(2):e1113. doi: 10.1002/cti2.1113. eCollection 2020.
4
Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy.在未进行辅助免疫治疗的情况下，对后颅窝脑膜瘤切除腔进行局部调强放射治疗（IMRT）后，在额部脑膜瘤中观察到可能的远隔效应。
Front Oncol. 2019 Oct 18;9:1109. doi: 10.3389/fonc.2019.01109. eCollection 2019.
5
Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis.细胞因子诱导的杀伤细胞辅助免疫治疗对II-IVB期鼻咽癌患者放化疗后的临床疗效：一项倾向评分分析
J Cancer. 2018 Oct 20;9(22):4204-4214. doi: 10.7150/jca.25790. eCollection 2018.
6
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.免疫化疗：剂量和方案依赖性以及与免疫疗法的联合应用。
Cancer Lett. 2018 Apr 10;419:210-221. doi: 10.1016/j.canlet.2018.01.050.
7
Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction.在新诊断的食管癌或胃食管交界腺癌患者中，使用特定医用食品进行营养干预后，体重和身体机能状态得到改善，血清前列腺素E2水平降低。
J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):32-44. doi: 10.1002/jcsm.12009. Epub 2015 Mar 31.
8
Skewed T-helper (Th)1/2- and Th17/T regulatory‑cell balances in patients with renal cell carcinoma.肾细胞癌患者中T辅助细胞（Th）1/2以及Th17/调节性T细胞平衡的倾斜
Mol Med Rep. 2015 Feb;11(2):947-53. doi: 10.3892/mmr.2014.2778. Epub 2014 Oct 27.
9
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma.Toll样受体8：增强铂耐药卵巢癌的固有免疫
Clin Pharmacol. 2013 May 23;5(Suppl 1):13-9. doi: 10.2147/CPAA.S40401. Print 2013.
10
Reduction of splenic immunosuppressive cells and enhancement of anti-tumor immunity by synergy of fish oil and selenium yeast.鱼油和酵母硒协同作用降低脾内免疫抑制细胞并增强抗肿瘤免疫。
PLoS One. 2013;8(1):e52912. doi: 10.1371/journal.pone.0052912. Epub 2013 Jan 22.
本文引用的文献
1
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.癌症与免疫细胞之间的相互作用：STAT3在肿瘤微环境中的作用
Nat Rev Immunol. 2007 Jan;7(1):41-51. doi: 10.1038/nri1995.
2
The role of the transcription factor Foxp3 in the development of regulatory T cells.转录因子Foxp3在调节性T细胞发育中的作用。
Immunol Rev. 2006 Aug;212:86-98. doi: 10.1111/j.0105-2896.2006.00426.x.
3
Checkpoint blockade in cancer immunotherapy.癌症免疫治疗中的免疫检查点阻断
Adv Immunol. 2006;90:297-339. doi: 10.1016/S0065-2776(06)90008-X.
4
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.癌症免疫监视与免疫编辑：免疫在抑制肿瘤发展及塑造肿瘤免疫原性中的作用。
Adv Immunol. 2006;90:1-50. doi: 10.1016/S0065-2776(06)90001-7.
5
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.p53癌症疫苗与化疗联合用于广泛期小细胞肺癌患者的治疗
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):878-87. doi: 10.1158/1078-0432.CCR-05-2013.
6
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.吲哚胺2,3-双加氧酶、肿瘤诱导的耐受性及反调节
Curr Opin Immunol. 2006 Apr;18(2):220-5. doi: 10.1016/j.coi.2006.01.002. Epub 2006 Feb 7.
7
The role of stroma in immune recognition and destruction of well-established solid tumors.基质在已形成的实体瘤免疫识别和破坏中的作用。
Curr Opin Immunol. 2006 Apr;18(2):226-31. doi: 10.1016/j.coi.2006.01.004. Epub 2006 Feb 3.
8
T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress.癌症中的T细胞功能障碍：髓样细胞和肿瘤细胞在调节氨基酸可用性和氧化应激中的作用。
Semin Cancer Biol. 2006 Feb;16(1):66-72. doi: 10.1016/j.semcancer.2005.10.001. Epub 2005 Nov 17.
9
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.癌症中的髓系抑制细胞：募集、表型、特性及免疫抑制机制
Semin Cancer Biol. 2006 Feb;16(1):53-65. doi: 10.1016/j.semcancer.2005.07.005. Epub 2005 Sep 15.
10
Immunotherapy for pancreatic cancer - science driving clinical progress.胰腺癌的免疫疗法——推动临床进展的科学
Nat Rev Cancer. 2005 Jun;5(6):459-67. doi: 10.1038/nrc1630.
Zotero 插件